BW-759
Modify Date: 2025-08-27 12:32:37
BW-759 structure
|
Common Name | BW-759 | ||
|---|---|---|---|---|
| CAS Number | 1359968-33-4 | Molecular Weight | 273.25 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C9H15N5O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BW-759Ganciclovir (INN) is an antiviral medication used to treat or prevent cytomegalovirus (CMV) infections. Ganciclovir is a synthetic analogue of 2′-deoxy-guanosine. It is first phosphorylated to ganciclovir monophosphate by a viral kinase encoded by the cytomegalovirus (CMV) gene UL97 during infection. Subsequently, cellular kinases catalyze the formation of ganciclovir diphosphate and ganciclovir triphosphate, which is present in 10-fold greater concentrations in CMV or herpes simplex virus (HSV)-infected cells than uninfected cells. A prodrug form with improved oral bioavailability (valganciclovir) has also been developed. |
| Name | BW-759 |
|---|
| Description | Ganciclovir (INN) is an antiviral medication used to treat or prevent cytomegalovirus (CMV) infections. Ganciclovir is a synthetic analogue of 2′-deoxy-guanosine. It is first phosphorylated to ganciclovir monophosphate by a viral kinase encoded by the cytomegalovirus (CMV) gene UL97 during infection. Subsequently, cellular kinases catalyze the formation of ganciclovir diphosphate and ganciclovir triphosphate, which is present in 10-fold greater concentrations in CMV or herpes simplex virus (HSV)-infected cells than uninfected cells. A prodrug form with improved oral bioavailability (valganciclovir) has also been developed. |
|---|
| Molecular Formula | C9H15N5O5 |
|---|---|
| Molecular Weight | 273.25 |